Thyroid hormone receptor agonist
Showing 26 - 50 of >10,000
Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Trial in Worldwide (Giredestrant,
Recruiting
- Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
- Giredestrant
- +5 more
-
Anchorage, Alaska
- +386 more
Jan 30, 2023
Thyroid Cancer, Medullary, Neuroendocrine Tumor of the Lung Grade 1 and 2, Neuroendocrine Tumor of the Thymus Grade 1 and 2
Recruiting
- Thyroid Cancer, Medullary
- +3 more
-
Basel, SwitzerlandUniversity Hospital Basel, Clinic for radiology and nuclear medi
May 23, 2022
Vitamin D on Hashimoto's Thyroiditis
Not yet recruiting
- Hashimoto Thyroiditis
- Vitamin D Drops
- (no location specified)
May 22, 2023
Thyroid Auto Transplantation Following Total Thyroidectomy in
Enrolling by invitation
- Thyroid Diseases
- total thyroidectomy followed by thyroid auto transplantation
-
Sohag, EgyptSohag University
Jun 26, 2023
s and Anti-thyroid Peroxidase Antibody Positivity in Recurrent
Completed
- Autoimmune Thyroiditis
- Recurrent Miscarriage
-
Zonguldak, TurkeyZonguldak Bulent Ecevit University Faculty of Medicine
Dec 26, 2022
Screening of Subclinical Hypothyroidism in Pregnant Women
Not yet recruiting
- Subclinical Hypothyroidism
- serum T.S.H level test
- (no location specified)
Mar 25, 2023
Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,
Recruiting
- Premenopausal Breast Cancer
- +2 more
- Goserelin
- +3 more
-
Taipei City, TaiwanDepartment of Oncology, National Taiwan University Hospital
Feb 7, 2023
Evaluation of Patients With Thyroid Disorders
Recruiting
- Hyperthyroidism
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Female Infertility Trial in Alexandria (gonadotropin releasing hormone-agonist, Progesterone)
Recruiting
- Female Infertility
- gonadotropin releasing hormone-agonist
- Progesterone
-
Alexandria, EgyptAlexandria University
Apr 5, 2022
Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer, HER2-Negative Breast Cancer, Metastatic Epithelial Ovarian Cancer
Terminated
- Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer
- +2 more
- Ribociclib
- +2 more
-
Boston, Massachusetts
- +2 more
Mar 16, 2022
Sarcopenia, Osteopenia Trial in Boston (Anamorelin Hydrochloride, Placebo)
Active, not recruiting
- Sarcopenia
- Osteopenia
- Anamorelin Hydrochloride
- Placebo
-
Boston, MassachusettsJean Mayer USDA Human Nutrition Research Center on Aging at Tuft
Feb 4, 2022
Type 2 Diabetes, Obesity Trial in Hellerup (Semaglutide 1.34 MG/ML [Ozempic], Glucose-dependent insulinotropic polypeptide
Recruiting
- Type 2 Diabetes
- Obesity
- Semaglutide 1.34 MG/ML [Ozempic]
- +3 more
-
Hellerup, Capital Region, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
May 19, 2022
HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast
Active, not recruiting
- HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer
- PF-06873600
- +2 more
-
Birmingham, Alabama
- +54 more
Nov 21, 2022
Central Precocious Puberty Trial (Debio 4326)
Not yet recruiting
- Central Precocious Puberty
- Debio 4326
- (no location specified)
Nov 8, 2023
Polycystic Ovary Syndrome Trial in Shanghai (GLP-1 RAs, calorie restricted diet)
Completed
- Polycystic Ovary Syndrome
- GLP-1 RAs
- calorie restricted diet
-
Shanghai, Shanghai, ChinaShanghai Tenth People' Hospital
Aug 2, 2022
Incidence of Retained Gastric Food on Endoscopy
Not yet recruiting
- Gastric Content Aspiration
- Esophagogastroduodenoscopy
- (no location specified)
May 16, 2023
REduction of LEvothyroxine in Adults; a SElf Controlled Study
Active, not recruiting
- Hypothyroidism
- Discontinuation of levothyroxine treatment
-
Leiden, NetherlandsLeiden University Medical Center
Apr 18, 2023
Endometrial Tumor Malignant Stage I Trial in Shanghai (Megestrol Acetate 160 MG Oral Tablet, Medroxyprogesterone Acetate 500 MG,
Recruiting
- Endometrial Neoplasm Malignant Stage I
- Megestrol Acetate 160 MG Oral Tablet
- +3 more
-
Shanghai, Shanghai, China, ChinaObstetrics and Gynecology Hospital, Fudan University
Mar 25, 2022
Graves' Disease Trial in Liverpool, Manchester (K1-70 intramuscular or K1-70 intravenous)
Completed
- Graves' Disease
- K1-70 intramuscular or K1-70 intravenous
-
Liverpool, United Kingdom
- +1 more
May 18, 2021
Metastatic Hormone-sensitive Prostate Cancer Trial in United States (Darolutamide (BAY1841788, Nubeqa), ADT)
Recruiting
- Metastatic Hormone-sensitive Prostate Cancer
- Darolutamide (BAY1841788, Nubeqa)
- ADT
-
Homewood, Alabama
- +11 more
Jan 13, 2023
Thyroid Dysfunction Trial in Assiut
Recruiting
- Thyroid Dysfunction
-
Assiut, EgyptHeba Ali
Feb 2, 2023
Hair Diseases, Alopecia, Hair Loss Trial in Manaus (DA-OTC-002)
Completed
- Hair Diseases
- +2 more
- DA-OTC-002
-
Manaus, BrazilHospital Oscar Nicolau
Oct 20, 2023
Relationship Between Ectopic Pregnancy and Thyroid Disorders
Completed
- Ectopic Pregnancy
- +2 more
- thyroid function tests
-
Siirt, TurkeySiirt Üniversity Medical Faculty
Dec 5, 2022
Type 2 Diabetes Trial in Doral (RGT001-075, Placebo)
Active, not recruiting
- Type 2 Diabetes Mellitus
- RGT001-075
- Placebo
-
Doral, FloridaAxon Clinical Research
May 17, 2022